ClinicalTrials.gg
RecruitingNCT07655232BRISK-IUpdated Oct 20, 2026

Pilot Study of a Behavioral Program for Resident Depression in Skilled Nursing Facilities

An interventional study of Interventions for Stressful Transitions in Later Life (InSTILL) for Individuals in Nursing Home Resident, Skilled Nursing Facility and Depression, sponsored by Massachusetts General Hospital. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Massachusetts General Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Nov 2025, registered Jun 2026).
  • Started Nov 2025; still recruiting 1 year later.
Updated Oct 20, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 163 studies in Depression by Massachusetts General Hospital — 24 open to participants now, 33 under way, none of them phase 3. Depression · Massachusetts General Hospital.

Planned enrollment
122nd of 153
20 · median 60
Started
2025
with 11 others
No phase
100 of 163
19 open now
Primary completion
2027-01
later than 5 of 32 live
Registered
160th of 163
by date

Among the 163 studies in Depression by Massachusetts General Hospital, this one is the 122nd largest by planned enrollment of the 153 interventional ones that give a count, is one of 12 that started in 2025, is one of 100 with no phase, reaches primary completion later than 5 of the 32 other live ones, and was the 160th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

24 of the 163 studies in Depression by Massachusetts General Hospital are open now, in 4 countries. Recruiting first, the newest first:

18 more — sign in →

By country, each count listing its studies:

All 24 open studies →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 163 studies in Depression by Massachusetts General Hospital, or all of them as a file.
02

Study summary

The goal of this clinical trial is to test a behavioral health program (Interventions for Stressful Transitions in Later Life, InSTILL, for Individuals) for skilled nursing facility residents. The main questions it aims to answer is whether the program is program is feasible, satisfactory, and helpful. Participants will join 6 bi-weekly sessions of the InSTILL program. Participants will complete assessments at three timepoints (all) and a brief-exit interview.

03

Conditions studied

  • Nursing Home Resident
  • Skilled Nursing Facility
  • Depression
  • Feasibility Studies

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Psychological distress, as indicated by a score Patient Health Questionnaire- 2 ≥ 2 OR Patient Health Questionnaire-9 ≥ 5
  • 5+ chronic conditions based on Elixhauser Comorbidity Index
  • Aged ≥ 18 years
  • Able and willing to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Intended length of SNF stay \< 7 days
  • More than mild cognitive impairment, as indicted by Brief Interview for Mental Status (BIMS) \<13
  • Participant's roommate is already enrolled in study/intervention
  • High risk of suicide/active documented SI per the PHQ-9, item 9 or otherwise
  • Participation in newly initiated psychotherapy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    InSTILL for Individuals

    Participants in this arm will participate in the Interventions for Stressful Transitions in Later Life (InSTILL), a behavioral health intervention tailored to the needs of short stay nursing facility residents. InSTILL for Individuals includes 6 sessions (2x per week for about 3 weeks) delivered in person or remotely.

    Behavioral: Interventions for Stressful Transitions in Later Life (InSTILL) for Individuals

Interventions

  • BehavioralInterventions for Stressful Transitions in Later Life (InSTILL) for Individuals

    The Interventions for Stressful Transitions in Later Life (InSTILL) intervention is for skilled nursing facility residents experiencing elevated levels of psychological distress. The intervention is designed to improve life management skills and emotion regulation skill with the goal of reducing depression symptoms.

06

What researchers measure

Primary outcomes

  1. Mean Total Score Treatment Credibility

    3-item self-report measure of participant's belief regarding how helpful the intervention will be for them. Higher scores (min = 0, max = 30) scores indicate greater credibility.

    Time frame: After session 1 of intervention, an average of 1 week after baseline

  2. Mean Total Score Client Satisfaction Questionnaire

    3-item self-report measure assessing patient satisfaction with the program. Higher total scores (min = 3, max = 12) indicate greater satisfaction.

    Time frame: Post intervention, an average of 4 weeks after baseline

  3. Percentage of Eligible Participants Enrolled

    Percentage of eligible approached individuals that are enrolled into the study.

    Time frame: Post intervention, an average of 4 weeks after baseline

  4. Percentage of Participants with Missing Data

    Percentage of all participants with no measure fully missing at 4-week follow-up.

    Time frame: 4 weeks after post-intervention

  5. Attendance Rate

    Percentage of participants completing 4/6 sessions of the intervention.

    Time frame: Post intervention, an average of 4 weeks after baseline

  6. Clinician Fidelity

    Percentage of InSTILL sessions delivered with 100% adherence on a study-specific Fidelity Checklist, based on those randomly sampled to be assessed.

    Time frame: Post intervention, an average of 4 weeks after baseline

  7. Number of Adverse Events

    Number of adverse events related to participation in the study.

    Time frame: 4 weeks after post-intervention

  8. Treatment Acceptability Survey

    Percentage of participants scoring above the scale midpoint on all Treatment Acceptability Survey items (developed for the current study).

    Time frame: Post intervention, an average of 4 weeks after baseline

  9. Percentage of Participants Meeting Participant Comprehension Criterion

    Percentage of participants scoring 7+ on a single-item cognitive load question (min=0, max=10)

    Time frame: Post intervention, an average of 4 weeks after baseline

Secondary outcomes

  1. Patient Health Questionnaire-9

    9-item self-report measure of depression symptoms. Higher scores (min=0, max=27) indicate greater depressive symptoms.

    Time frame: Baseline; Post intervention, an average of 4 weeks after baseline; 4 weeks after post-intervention

  2. Selection, Optimization, and Compensation (SOC) in Everyday Use

    4-item self-report measure of the application of selection, optimization, and compensation strategies in daily life. Items are averaged for a composite score, with higher scores indicate greater SOC strategy use (Range = 1-6).

    Time frame: Baseline; Post intervention, an average of 4 weeks after baseline; 4 weeks after post-intervention

  3. Committed Action Questionnaire

    8-item self-report measure of pursuit of valued goals despite challenges and difficulties. Higher scores indicate greater use and effectiveness of emotional regulation skills (Range = 0-48).

    Time frame: Baseline; Post intervention, an average of 4 weeks after baseline; 4 weeks after post-intervention

  4. General Anxiety Disorder-7

    7-item self-report measure of anxiety symptoms. Higher scores indicate higher levels of anxiety symptoms (Range = 0-21).

    Time frame: Baseline; Post intervention, an average of 4 weeks after baseline; 4 weeks after post-intervention

  5. Euro QoL-5D 5L

    6-item self-report measure of subjective health-related quality of life. Higher scores indicate worse health-related quality of life (Range = 5-25). The scale also includes a separately scored single-item global health indicator, asked on a 0-100 scale with higher scores indicate higher subjective health-related quality of life.

    Time frame: Baseline; Post intervention, an average of 4 weeks after baseline; 4 weeks after post-intervention

  6. COREQ

    4-item self-report of nursing facility satisfaction. Higher averaged scores indicate greater facility satisfaction (Range = 1-5).

    Time frame: Post intervention, an average of 4 weeks after baseline

  7. University of Washington Resilience Scale Short Form

    4-item self-report of an individual's perceived resilience. Summed scores will be converted to T-scores using a conversion table.

    Time frame: Baseline; Post intervention, an average of 4 weeks after baseline; 4 weeks after post-intervention

  8. Psychotropic medication use

    Chart or self reported psychotropic medication use. Patients will self-report changes to medication, including dosage, at post-intervention and follow-up

    Time frame: Baseline; Post intervention, an average of 4 weeks after baseline; 4 weeks after post-intervention

  9. Re-hospitalization

    Resident re-hospitalization during the study period

    Time frame: Post intervention, an average of 4 weeks after baseline; 4 weeks after post-intervention

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2025 (actual). Primary completion is estimated for Jan 2027, 13 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 13 months is below that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 20, 2026: primary completion Oct 2026 → Jan 2027 and completion Dec 2026 → Feb 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 9, 2026
First posted
Jun 17, 2026
StartActual
Nov 17, 2025
Primary completionEst.
Jan 1, 2027was Oct 2026
CompletionEst.
Feb 28, 2027was Dec 2026
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Oct 1, 2026→Jan 1, 2027
Oct 20, 2026
Study completion
Dec 31, 2026→Feb 28, 2027
Oct 20, 2026
Show all 1 update
  1. Oct 20, 2026
    Primary completion Oct 1, 2026→Jan 1, 2027
    Study completion Dec 31, 2026→Feb 28, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07655232
Responsible party
Evan Plys (Assistant Professor of Psychology, Massachusetts General Hospital) — Principal investigator
First posted
Jun 17, 2026
Start date
Nov 17, 2025
Primary completion
Jan 1, 2027 (estimated)
Completion
Feb 28, 2027 (estimated)
Last update
Oct 20, 2026

Study contacts

BRISK Study Coordinator
Contact
brisk@mgb.org
617-643-9406
Evan Plys, PhD
principal investigator · Massachusetts General Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion